कृपया अन्य खोज का प्रयास करें
Medesis Pharma S.A. operates as a biopharmaceutical company. The company’s products include NanoLithium (NP03) for the treatment of Alzheimer’s disease; NanosiRNA HD and NanoP42T to treat Huntington’s disease; NanoLithium for the prevention and treatment of psychiatric disorders; NanoManganese (NP02), a radiation protection drug; and NU01 plutonium decorporation and NU02 cesium decorporation nuclear drugs. It also develops oncology drugs, including NanosiRNA IFNAR and NanoManganese Radiotherapy Glioblastoma. The company was founded in 2003 and is based in Montpellier, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Cedric Navas | - | 2021 | Member of the Supervisory Board |
Sylvie Mader | - | - | Member of International Scientific Advisory Board - Oncology |
Olivier Connes | - | 2021 | Chairman of the Supervisory Board |
Jean-Marie Cazaledes | - | 2021 | Member of the Supervisory Board |
Serge Gauthier | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Gerald Batist | - | - | Member of International Scientific Advisory Board - Oncology |
Jacques Touchon | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Jean-Philippe Causse | - | 2021 | Member of the Supervisory Board |
Claudio Cuello | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Paul Loubet | - | - | Member of International Scientific Advisory Board - Infectious diseases |
Guy A. Rouleau | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Bernard Connes | - | 2021 | Vice-Chairman of the Supervisory Board |
George Lyketsos | - | 2023 | Member of Scientific Advisory Board |
Cecilia Marelli | - | 2023 | Member of Scientific Advisory board |
Edward N. Wilson | - | 2023 | Member of Scientific Advisory Board |
Maria Soto Martin | - | 2023 | Member of Scientific Advisory board |
Zahinoor Ismail | - | 2023 | Member of Scientific Advisory Board |
Mahmoud Pouladi | - | 2023 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है